Literature DB >> 5985307

Chemical modification of lincomycin.

B J Magerlein, R D Birkenmeyer, F Kagan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5985307

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  13 in total

1.  Interaction of the antibiotics clindamycin and lincomycin with Escherichia coli 23S ribosomal RNA.

Authors:  S Douthwaite
Journal:  Nucleic Acids Res       Date:  1992-09-25       Impact factor: 16.971

2.  Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 2. Synthesis of 7(S)-7-deoxy-7-(4-morpholinocarbonylphenylthio)lincomycin and its 3-dimensional analysis with rRNA.

Authors:  Yoshinari Wakiyama; Ko Kumura; Eijiro Umemura; Satomi Masaki; Kazutaka Ueda; Takashi Watanabe; Mikio Yamamoto; Yoko Hirai; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2015-12-16       Impact factor: 2.649

3.  Synthesis and SARs of novel lincomycin derivatives Part 5: optimization of lincomycin analogs exhibiting potent antibacterial activities by chemical modification at the 6- and 7-positions.

Authors:  Yoshinari Wakiyama; Ko Kumura; Eijiro Umemura; Satomi Masaki; Kazutaka Ueda; Yasuo Sato; Yoko Hirai; Yoshio Hayashi; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

4.  Microbiological and pharmacological behavior of 7-chlorolincomycin.

Authors:  B R Meyers; K Kaplan; L Weinstein
Journal:  Appl Microbiol       Date:  1969-05

5.  Antibiotic inhibitors of the bacterial ribosome.

Authors:  B Weisblum; J Davies
Journal:  Bacteriol Rev       Date:  1968-12

6.  Synthesis and structure-activity relationships of novel lincomycin derivatives part 3: discovery of the 4-(pyrimidin-5-yl)phenyl group in synthesis of 7(S)-thiolincomycin analogs.

Authors:  Yoshinari Wakiyama; Ko Kumura; Eijiro Umemura; Satomi Masaki; Kazutaka Ueda; Yasuo Sato; Takashi Watanabe; Yoko Hirai; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2016-10-05       Impact factor: 2.649

7.  Clinical uses and control of rifampicin and clindamycin.

Authors:  I Phillips
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

8.  Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 4: synthesis of novel lincomycin analogs modified at the 6- and 7-positions and their potent antibacterial activities.

Authors:  Yoshinari Wakiyama; Ko Kumura; Eijiro Umemura; Kazutaka Ueda; Takashi Watanabe; Keiko Yamada; Takafumi Okutomi; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2017-05-31       Impact factor: 2.649

9.  Microbial transformation of antibiotics: phosphorylation of clindamycin by Streptomyces coelicolor Müller.

Authors:  J H Coats; A D Argoudelis
Journal:  J Bacteriol       Date:  1971-10       Impact factor: 3.490

10.  Streptococcal pharyngitis therapy: comparison of clindamycin palmitate and potassium phenoxymethyl penicillin.

Authors:  M Stillerman; H D Isenberg; R R Facklam
Journal:  Antimicrob Agents Chemother       Date:  1973-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.